EFTA Document EFTA02085137

To: Jeffrey E. eevacationiagmaitcomi From: Sent Subject Fwd: Last Response from Joe Thakuria Jan. 12, 2015 Thur 3/5/2015 12:16:50 PM Below from Joe... Begin forwarded message: From: Joseph Thakuria Subject: Re: Last Response rom oe to cur a an. 2, 2015 Date: March 5.2015 at 12:00:22 AM EST To: Cc: george church my apologies to Jeffrey for the delay. I can only re-emphasize this is research and that Jeffrey will still be among the first few hundred to get this type of clinical analysis along with a portable copy of their data. Also, as I previously emailed, once we get through this first batch of data, I'm confident I'll be able to provide some additional sequencing data for free in the future if he's interested. Lastly, I just want to make sure you're aware this exome sequencing is not part of the pgp - so George is not responsible for any delay. (I'm perfectly happy with George being cc'd on any of our communications though.) Sony again for the delay, Joe On Wed, Mar 4, 2015 at 9:59 AM, wrote: Hello Joe and George...Jeffrey requested I forward to you both this past email stream...Please note Jan 12, 2015 Jeffrey was told around early Feb. he should have results...but again was told today there are more delays... Thank you, Begin forwarded message: From: "Jeffrey E." leevacationacimail.coni> Subject: Re: Last Response from Joe Thakuria Jan. 12, 2015 Date: March 4, 2015 at 9:56:01 AM EST To: send this to him and to geoge EFTA_R 1_00673685 EFTA02085137 On Wed, Mar 4, 2015 at 3:49 PM Begin forwarded message: wrote Subject: Re: Any Update for Jeffrey Epstein Da To Thx - I'm available to discuss if necessary. Joe On Mon, Jan 12, 2015 at 12:04 PM wrote: Great! thank you very much for this! Will pass along! On Jan 12, 2015, at 12:01 PM, Joseph Thakuria wrote: Hi Please pass on that we are very close. The study should have final / full approval in I- 2 weeks; with analysis of his data completed in another 1-2 weeks. So please give until early Feb. I apologize for this delay. He is delayed along with others in YPO (in fact, I will prioritize Jeffs analysis). The second batch will not have this type of wait. It's mainly the result of being in the first pilot group. Thanks, Joe On Fri, Jan 9, 2015 at 8:31 AM, wrote: Hi Joe...any update?. On Dec 9, 2014, at 6:17 PM, Joseph EFTA_R1_00673686 EFTA02085138 Thakuria wrote: OK, we'll do a deep dive on those gene associations for his data. On Tue, Dcc 9, 2014 at 6:00 PM wrote: Jeffrey replied back! He says: diabetes and kidney issues! Thanks so much! On Dec 9, 2014, at 5:06 PM, Joseph Thakuria wrote: Please stress that providing the info is completely voluntary. Theoretically it should make for a more personalized analysis and it gives him the opportunity to let me know if there is any medical condition he specifically wants me to do a deep dive with his data on. (The general screen for medically EFTA_R1_00673687 EFTA02085139 serious mutations will happen of course even without any additional info from him.) Joe On Tue, Dec 9, 2014 at 4:54 P wrote: Hi Joe! thank you so very much for the update...I am not sure if Jeffrey would like to provide any family medical history but will ask and get back to you...great to know things arc moving along!! On Dec 9, 2014, at 4:28 PM, Joseph Thakuria ote: H 0 EFTA_R1_00873688 EFTA02085140 o C o u ZS; c cet- %.; E ce C R >YR] v.. tiro F R C o i o at o a) x o e.) COI EFTA02085141 e' V $ e e n d 3 of fr r d at a h 0 ul b d V ai la bl 0 n 0 - 3 w EFTA R1_00873690 EFTA02085142 k d I e x p e ct e V r t hi b 0 hi p p d p d 0 EFTA_R1_00673691 EFTA02085143 0 n t h. 0 0 k D w if of w fr n is 0 0 lu n to ri ly p 0 vi d y p rs 0 n EFTA_R1_00673692 EFTA02085144 al m c di c al 0 r fa m it y m c di c al hi st 0 r y 9 W e c a n p C Es 0 n al iz c t h c a n al y si s b EFTA_R1_00673693 EFTA02085145 a s e d 0 n t hi s in f 0 F 0 r c x a tn p1 c, f 0 r p e 0 pi e w it h a st r 0 n g fa m it y In st 0 EFTA_R1_00873694 EFTA02085146 0 b r st a a n r d 0 k 0 r 0 h 0 0 k at b EFTA_R1_00673695 EFTA02085147 r e a st c a n c e r a s s 0 ci at e d g e n e s in a d di ti 0 n t 0 t h c b a si c a n al y st s f EFTA_R1_00673696 EFTA02085148 0 t h in di vi d al s. S ci fi al ly fa m it m di e al hi st 0 r 0 n si b s, a r EFTA_R1_00873697 EFTA02085149 n is a r d p d n is a b cf ul - a cl 1 a a hi st 0 r 0 f in h EFTA_R1_00673698 EFTA02085150 ri to d di 0 r d rs - ci al ly if it is r r d n rl y 0 n et in li fe T h a n k in EFTA_R1_00873699 EFTA02085151 a d v a n c e f 0 r P a s si n 8 0 n t hi s in f 0 Best, Joe On Dec 8, 2014 12:46 PM w r EFTA R1_00873700 EFTA02085152 EFTA_R1_00673701 o X V 0 1...1 0 4) U.= u CJ C Op.. C as = sas 0 L. C.) a 0 o EFTA02085153 r f p k n m W r 0 h r h h p 0 J EFTA_R1_00673702 EFTA02085154 h C k please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to je ac zn gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA_R1_00673703 EFTA02085155